Top 6 BioPharma Movers of the Week
These biotech companies stood out from the rest with incredible gains or losses over the course of the past week.
All Work
Chris Lange
Is Aflac Still a Buy?
Aflac Inc. (NYSE: AFL) recently gave its outlook, but considering a weakening yen over the past month, analysts have become wary. Janney Capital recently reduced its earnings per share (EPS) estimate to $6.30 from…
NRG Continues to Fall as CEO Steps Down
NRG Energy has announced that David Crane is stepping down as president and chief executive officer, effective immediately.
Why Oppenheimer Wants to Chase Warren Buffett in Phillips 66
Phillips 66 has long been a staple of Warren Buffett's portfolio and it is now attracting the attention of an Oppenheimer analyst.
KaloBios Continues to Rally on Private Placement
KaloBios Pharmaceuticals continues to vastly outperform the broad markets through December after Martin Shkreli took the helm.
Big Lots Rises After Meeting Earnings
Big Lots reported mixed fiscal third-quarter financial results before the market opened on Friday.
Why Merrill Lynch Downgraded Railroads
Weakness in coal calls into question the strength of railroads. Merrill Lynch weighed in on some rail companies.
Zumiez Falls Sharply on Missed Guidance
Zumiez reported better-than-expected fiscal third-quarter financial results before the markets opened on Friday.
Why Ambarella Earnings Aren’t Enough to Overcome Its Outlook
Ambarella, Inc. (NASDAQ: AMBA) reported its fiscal third quarter financial results after the markets closed on Thursday. The company had $1.08 in earnings per share (EPS) on $93.2 million in revenue compared to consensus…
Ulta Crushes Earnings With Strong Comps
Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA) released its fiscal third quarter earnings report after the markets closed Thursday. The company had $1.11 in earnings per share (EPS) on $910.7 million in revenue…
How Analysts View Verint After Earnings
Verint Systems is adjusting its go-to-market strategy to counter the slowdown in its purchase approvals. However the resulting update to guidance was not what analysts and investors were looking for.
SEC Charges 3 Chicago Traders for Spoofing and Order Mismarking
The U.S. Securities and Exchange Commission (SEC) reported fraud charges against three Chicago-based traders accused of circumventing market structure rules in a pair of options trading schemes. The SEC Enforcement Division alleges that twin…
Foamix Soars on Positive Phase 2 Results
Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) was leading the bulls early in Thursday’s session on positive results from a Phase 2 study. The company announced positive top-line results from its Phase 2 clinical study of…
Rite Aid Announces November Sales
Rite Aid reported its sales results for its retail pharmacy segment for the month of November before the markets opened Thursday.
Why Analysts and Investors Are Endorsing Avago and Broadcom So Much After Earnings
Avago Technologies Ltd. (NASDAQ: AVGO) released fiscal fourth-quarter financial results on Wednesday that completely wowed analysts and investors alike.
How Kroger Comps and Guidance Saved Earnings
Kroger released disappointing fiscal third-quarter financial results before the markets opened on Thursday.
Medtronic Earnings Solid as Covidien Integration Continues
Medtronic reported better-than-expected fiscal second-quarter financial results before the markets opened on Thursday.
Box Earnings Meet Estimates but Fail to Impress
Box reported mixed fiscal third-quarter financial results after the markets closed on Wednesday.
What to Expect From Medtronic Earnings
Medtronic is scheduled to report its fiscal second-quarter financial results after the markets close on Thursday.
SEC Settles Red Flag and Fraud Charges With National Audit Firm
The U.S. Securities and Exchange Commission announced that Grant Thornton, a national audit firm, and two of its partners agreed to settle charges.